Explore 3 Stock Ideas & Industry Insights Download Free Report

Advantis Corp

Healthcare US ADVT

0.0USD
0.00(0%)

Last update at 2026-06-22T20:00:00Z

52 Week Range

--
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00978M
  • Volume200692
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - - - -0.02364M
Minority interest - - - - -
Net income - - - - -0.02364M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit - - - - 0.76M
Reconciled depreciation - - - - -
Ebit - - - - -
Ebitda - - - - -0.02297M
Depreciation and amortization 0.23M 0.24M 0.21M 0.17M -
Non operating income net other - - - - -
Operating income - - - - -0.02297M
Other operating expenses - - - - 0.85M
Interest expense - - - - 0.00068M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue - - - - 0.83M
Total operating expenses - - - - 0.79M
Cost of revenue - - - - 0.06M
Total other income expense net - - - - -0.00067M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Type yearly yearly yearly yearly yearly
Date 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total assets 0.54M 0.27M 0.05M 0.00762M 0.00001M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.22M 0.10M 0.00150M - -
Total liab 1.84M 1.52M 1.34M 1.29M 1.39M
Total stockholder equity -1.29569M -1.25563M -1.28552M -1.27849M -1.38708M
Deferred long term liab - - - - -
Other current liab 1.12M - - - -
Common stock 0.10M 0.10M 0.08M 0.07M 0.07M
Capital stock - - - - -
Retained earnings -1.65271M -1.64600M -1.53231M -1.42622M -1.53481M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.30M 0.14M 0.00916M 0.00762M 0.00001M
Cash and equivalents - - - - -
Total current liabilities 1.12M 0.80M 0.48M 0.43M 1.39M
Current deferred revenue - - - - -
Net debt 0.42M - - - -
Short term debt - 0.36M 0.25M 0.36M 0.16M
Short long term debt - 0.36M 0.25M 0.36M 0.16M
Short long term debt total 0.72M - - - -
Other stockholder equity 0.25M - - - -
Property plant equipment - - - - -
Total current assets 0.54M 0.27M 0.05M 0.00762M 0.00001M
Long term investments - - - - -
Net tangible assets - -1.25563M -1.28552M -1.27849M -1.38708M
Short term investments - - - - -
Net receivables 0.03M 0.02M 0.03M - -
Long term debt - 0.72M 0.85M 0.85M -
Inventory - 0.00850M 0.00697M - -
Accounts payable 0.00153M 0.44M 0.23M 0.07M 1.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.00357M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2019-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Type yearly yearly yearly yearly yearly
Date 2019-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Investments - - - - -
Change to liabilities - 0.19M 0.07M -0.97597M 0.06M
Total cashflows from investing activities - -0.10000M -0.10000M -0.10000M -
Net borrowings - - -0.02000M 0.88M 0.88M
Total cash from financing activities - 0.03M 0.08M 0.88M 0.02M
Change to operating activities - 0.02M -0.04318M -0.04318M -0.04318M
Net income - -0.11369M -0.10609M 0.11M -0.08192M
Change in cash - 0.13M 0.00154M 0.00762M 0.00001M
Begin period cash flow 0.30M - - - -
End period cash flow 0.30M - - - -
Total cash from operating activities - 0.09M -0.07752M -0.86738M -0.02427M
Issuance of capital stock - - - - -
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - 0.13M 0.10M 0.10M 0.02M
Other cashflows from financing activities - - - - -
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow - - - - -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ADVT
Advantis Corp
- -% - - - 1.47 - 0.16 -0.111
ZTS
Zoetis Inc
1.26 1.67% 77.16 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
0.23 0.75% 30.79 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
- -% 149.28 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG
0.47 1.09% 43.41 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

Profile

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.

Advantis Corp

1048 Irvine Avenue, Newport Beach, CA, United States, 92660

Key Executives

Name Title Year Born
Mr. Darren Cherry Chief Exec. Officer NA
Mr. Geoffrey Broderick Corp. Counsel NA
Mr. Chris Thue Chief Compliance Officer of Operations NA
Mr. Darren Cherry Chief Executive Officer NA
Mr. Geoffrey Broderick Corporate Counsel NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.